LOPERAMIDE HCL TABLETS USP, 2 mg, ANTI-DIARRHEAL, 24 caplets per carton, OTC, Distributed by Dru...
FDA Drug Recall #D-0391-2019 - Class III, December 26, 2018
Recall Summary
| Recall Number | D-0391-2019 |
| Classification | Class III, Low risk |
| Date Initiated | December 26, 2018 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Sun Pharmaceutical Industries, Inc. |
| Location | Cranbury, NJ |
| Product Type | Drugs |
| Quantity | 5040 cartons |
Product Description
LOPERAMIDE HCL TABLETS USP, 2 mg, ANTI-DIARRHEAL, 24 caplets per carton, OTC, Distributed by Drug Mart-Food Fair Medina Ohio 44256 Ohm Laboratories Inc. UPC 0 93351 11270 6 NDC#:53943-123-24
Reason for Recall
Labeling Not Elsewhere Classified: The front panel indicates 24 caplets whereas the side panel indicates 12 caplets. The drug product carton contains 24 caplets.
Distribution Pattern
OH
Lot / Code Information
Lot: 2979325, EXP 5/5021
Other Recalls from Sun Pharmaceutical Industries, Inc.
| Recall # | Classification | Product | Date |
|---|---|---|---|
| D-1032-2020 | Class II | Doxycycline Capsules, USP, 75 mg, 100-count bot... | Mar 13, 2020 |
| D-1033-2020 | Class II | Doxycycline Capsules, USP, 100 mg, 50-count bot... | Mar 13, 2020 |
| D-1047-2020 | Class II | Atorvastatin Calcium Tablets, USP 40 mg, Rx onl... | Mar 9, 2020 |
| D-0788-2020 | Class II | Testosterone Cypionate for Injection, 2,000 mg/... | Jan 14, 2020 |
| D-0787-2020 | Class II | Testosterone Cypionate for Injection, USP, 1,00... | Jan 14, 2020 |
Frequently Asked Questions
Stop using the medication immediately and contact your pharmacist. A mislabeling recall can range from a minor technical error (wrong font size) to a serious mix-up where one drug is inside another drug's packaging. If you received a medication that looks or acts differently than expected, or if you experienced unexpected effects, tell your doctor immediately. The pharmacist can verify whether your specific lot is affected and provide a replacement. Report any adverse effects experienced to FDA MedWatch at 1-800-FDA-1088.
Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications, even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.
Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.
What Should You Do?
Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications, use a drug take-back program.